ASMA HAYDAR: Open Payments
NPI 1386236909 · DEARBORN HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 8 payments from 7 companies in 2025. Trend: 2023 $229 · 2024 $284 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $125 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Dexcom, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: JOURNAVX, CAPLYTA, Auvelity, Dexcom G6 Transmitter, TRELEGY ELLIPTA, AIRSUPRA, AREXVY, Ozempic.
Industry payments across MI — which companies pay providers there.
